Skip to main content
. 2014 Sep;88(17):9514–9528. doi: 10.1128/JVI.00802-14

TABLE 2.

Antigen-specific CD8+ T cell inhibition of HIV-1 replication

Patient ID Reduction value (log10)a
Unstimulated Env
Gag
Pol
Nef
E1 E2 E3 E4 G1 G2 G3 P1 P2 P3 P4
VC9 <0.39 <0.39 <0.39 0.44 0.53 0.45 0.64 <0.39 0.56 0.63 0.52 0.61 0.74
VC11 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39 0.40 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39
VC15 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39 0.42 <0.39 <0.39 0.45 0.50 <0.39 0.47
VC16 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39 0.44 <0.39 <0.39 <0.39 0.42
VC20 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39 0.48 <0.39 <0.39 <0.39 <0.39 <0.39 0.42
VC23 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39 0.40 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39
VC24 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39
VC26 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39 0.43 0.40 <0.39 <0.39 <0.39 0.45
VC27 <0.39 <0.39 <0.39 <0.39 0.54 0.59 0.63 <0.39 0.46 <0.39 0.42 0.41 0.57
VC28 <0.39 <0.39 0.47 0.41 0.42 0.43 0.42 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39
VC29 <0.39 0.51 0.41 <0.39 <0.39 0.41 0.47 <0.39 <0.39 <0.39 <0.39 <0.39 0.49
VC30 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39 0.45 <0.39 <0.39 <0.39 <0.39 <0.39 <0.39
Totalb 0 1 2 2 3 4 9 1 4 2 3 2 7
a

The log10 reduction values for HIV-1 peptide-specific soluble inhibition by CD8+ T cells from HIV-1 VCs are shown. An sVIA was used to measure the inhibitory capacities of antigen-stimulated primary CD8+ T cells from 12 HIV-1+ virus controllers. Virus inhibition was measured as log reduction in CH040.c (transmitted/founder virus) replication without CD8+ T cell effectors. Values of >0.39-log-unit reduction in virus replication compared to a no-CD8+ T cell control indicate significant inhibition and are reported (boldface). A value of <0.39 (lightface) indicates a nonsignificant log10 reduction value. The peptide pools were divided as follows to represent HIV-1 regions based on the HXB2 amino acid number: Env1 (E1), amino acids 4 to 296 (gp120); Env2 (E2), amino acids 297 to 488 (gp120); Env3 (E3), amino acids 489 to 602 (gp41); Env4 (E4), amino acids 603 to 840 (gp41); Gag1 (G1), amino acids 1 to 128 (p17); Gag2 (G2), amino acids 131 to 361 (p24); Gag3 (G3), amino acids 362 to 486 (p17); Pol1 (P1), amino acids 1 to 152 (protease); Pol2 (P2), amino acids 156 to 447 (p51); Pol3 (P3), amino acids 452 to 709 (p51 plus p15); Pol4 (P4), amino acids 711 to 988 (p31); Nef, amino acids 1 to 193.

b

Total number of values of >0.39-log-unit reduction in virus replication compared to a no-CD8+ T cell control.